FDA approves Merck’s drug for rare, deadly lung condition
The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.
Shares of the salad chain surged 35% Friday after the company beat Wall Street's forecast for first-quarter results.
Fat Brands' portfolio includes Fatburger, Johnny Rockets and Twin Peaks.
Rivian, Lucid and Nikola this week each detailed plans to reduce costs while attempting to grow operations and make their...
While the spring sales typically have more than a dozen works offered for more than $30 million each, this year...
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having...
The FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent...